Brian Kotzin

Brian Kotzin

Direktor/Vorstandsmitglied bei BIORA THERAPEUTICS, INC.

Vermögen: 1 Mio $ am 31.10.2026

76 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Brian L.
Kotzin
is currently Director at Benaroya Research Institute at Virginia Mason, Independent Director at Biora Therapeutics, Inc. since 2019, Non-Executive Director at argenx SE since 2024, Director at Genascence Corp.
since 2022, and Member of the Association of American Physicians and the American Society of Clinical Investigation.
Former positions include Chairman of the Immunological Sciences Study Section at the National Institutes of Health, Director at the American College of Rheumatology, Federation of Clinical Immunology Societies, and Vera Therapeutics, Inc., Director and Head of Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, Director of the Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center from 1981 to 2004, Independent Director at Kyverna Therapeutics, Inc. from 2019 to 2024, Independent Director at Rigel Pharmaceuticals, Inc. from 2017 to 2024, Vice President of Global Clinical Development and Head of Inflammation at Amgen, Inc. from 2004 to 2015, Chief of the Rheumatology Section at Veterans Administration Medical Center, Professor at National Jewish Health, Inc., and Chief Medical Officer at Nektar Therapeutics in 2023.
Education includes undergraduate studies at the University of Southern California and a doctorate from Stanford University School of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.10.2026 1.590 ( 0 % ) 1 Mio $ 31.10.2026

Aktive Positionen von Brian Kotzin

UnternehmenPositionBeginn
BIORA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.06.2019
ARGENX SE Direktor/Vorstandsmitglied 07.05.2024
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.01.2022
American Society of Clinical Investigation
Corporate Officer/Principal -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Brian Kotzin

UnternehmenPositionEnde
RIGEL PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 16.09.2024
KYVERNA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 13.09.2024
NEKTAR THERAPEUTICS Technik-/Wissenschafts-/F&E-Leiter 01.06.2023
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Brian Kotzin im Detail an

Ausbildung von Brian Kotzin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

93

Beziehungen ersten Grades

19

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen19

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Commercial Services

American Society of Clinical Investigation

Commercial Services

Health Technology

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Autoimmunity Center of Excellence

  1. Börse
  2. Insider
  3. Brian Kotzin